This page lists the SEC filings reported by Nantahala Capital Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-03-11 | Nantahala Capital Management, LLC | Rezolute, Inc. | 4,118,164 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Aptose Biosciences Inc. | 120,132 | 1.5% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Cidara Therapeutics, Inc. | 1,546,745 | 1.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Fortress Biotech, Inc. | 372,562 | 4.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | IMAX CORP | 2,658,753 | 4.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | RMR GROUP INC. | 404,063 | 2.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Spyre Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Bioventus Inc. | 5,977,471 | 9.5% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | CODEXIS, INC. | 4,592,903 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | DHI GROUP, INC. | 2,639,687 | 5.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | LUXFER HOLDINGS PLC | 1,809,645 | 6.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Red Violet, Inc. | 1,205,678 | 8.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | STRATA Skin Sciences, Inc. | 3,128,132 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | uniQure N.V. | 3,158,027 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Lyra Therapeutics, Inc. | 4,752,324 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | ESTABLISHMENT LABS HOLDINGS INC. | 2,470,154 | 9.5% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | DarioHealth Corp. | 2,761,140 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | RumbleOn, Inc. | 4,416,506 | 12.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | SOLENO THERAPEUTICS INC | 3,068,031 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | ABEONA THERAPEUTICS INC. | 2,499,781 | 9.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.